Hwa-Ming Yang

Learn More
Bifeprunox is a partial dopamine agonist with a unique receptor-binding profile and potential antipsychotic properties. The current study evaluated the efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia. In this 6-week, double-blind, placebo-controlled study, 589 patients were randomly assigned to once-daily treatment(More)
A panel of experts formulated relevant domains of sexual function with a focus on sexual interest and desire. The resulting 10-item scale, the Menopausal Sexual Interest Questionnaire (MSIQ), was examined for reliability (internal consistency and test-retest repeatability), construct validity (concurrent, convergent, and discriminant), sensitivity, and(More)
OBJECTIVE To compare the efficacy and tolerability of dronabinol, ondansetron, or the combination for delayed chemotherapy-induced nausea and vomiting (CINV) in a 5-day, double-blind, placebo-controlled study. RESEARCH DESIGN AND METHODS Patients receiving moderately to highly emetogenic chemotherapy received dexamethasone (20 mg PO), ondansetron (16 mg(More)
  • 1